Attached files

file filename
EX-3.1 - CERTIFICATE OF INCORPORATION AS AMENDED ON MAY 28, 2009 - Chelsea Therapeutics International, Ltd.dex31.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - Chelsea Therapeutics International, Ltd.dex312.htm
EX-32.1 - CERTIFICATION OF CEO PURSUANT TO SECTION 906 - Chelsea Therapeutics International, Ltd.dex321.htm
EX-32.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 906 - Chelsea Therapeutics International, Ltd.dex322.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Chelsea Therapeutics International, Ltd.dex231.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - Chelsea Therapeutics International, Ltd.dex311.htm
10-K - FORM 10-K - Chelsea Therapeutics International, Ltd.d10k.htm

EXHIBIT 23.2

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the registration statements on Forms S-3 (Nos. 333-132330, 333-141964, 333-146422 and 333-161236) and Forms S-8 (Nos. 333-137782, 333-144061 and 333-160256) of our report dated March 10, 2008 relating to the consolidated financial statements of Chelsea Therapeutics International, Ltd. and included in this Annual Report on Form 10-K of Chelsea Therapeutics International, Ltd. for the year ended December 31, 2009.

/s/    J.H. Cohn LLP

Roseland, New Jersey

March 10, 2010